Impaired insulin secretion in human diabetes mellitus. I. The effect of alpha-adrenergic inhibition.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000503:physiopathology*; D005260:Female; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D009530:Nicergoline / Q000494:pharmacology; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D005947:Glucose; D009530:Nicergoline